A researcher discovers mid-study that a participant is experiencing unexpected adverse effects. What is the FIRST ethical obligation?
-
A
Consult the IRB before taking any action
-
B
Immediately report to the sponsor and pause enrollment
-
C
Protect participant safety and report the finding promptly
-
D
Complete data collection to avoid compromising study validity